Adelphi University

Adelphi University, a tax-exempt private research university headquartered in Garden City, New York, operates as a federal grant recipient conducting research and educational programming across behavioral and cognitive neuroscience, STEM workforce development, health professions training, prebiotic chemistry, and imaging technology. The university acts as a prime recipient on 68 of its 85 federal awards (80%) and as a sub-recipient on 17 awards (20%), with no federal contracts in its footprint — its federal engagement is exclusively grant-based. Adelphi holds no SBA certifications and competes full-and-open across all funding sources.

The National Science Foundation is Adelphi's largest and most active customer by volume, with 10 awards across multiple research domains. The Department of Health and Human Services, operating through the Health Resources and Services Administration and the National Institutes of Health, anchors 14 awards focused on behavioral health workforce training and mental health research. The Department of the Navy's Bureau of Medicine and Surgery holds 6 awards valued at $93 thousand combined potential value, placed against a single Basic Ordering Agreement (N0018912GZ013). The Federal Emergency Management Agency placed 5 awards, primarily for COVID-19 response and emergency management costs during 2022–2024. Collectively, the top five customer agencies cover 41% of award volume.

Representative prime recipient work includes a $2,499,816 NSF Project Grant (CFDA 47.076, Division of Undergraduate Education) supporting the "Ensuring STEM Student Success Through an Integrative Support Program," which provides financial aid and mentoring to twenty-five low-income undergraduate STEM majors over six years; a $388,026 National Institute of Mental Health Project Grant (CFDA 93.242) for research on social computational phenotypes in transdiagnostic mental health spectra; and a $311,035 NSF Project Grant (CFDA 47.074) investigating prebiotic peptides and the origin of biological energy. Adelphi also holds a $2.5 million-plus cooperative agreement with the National Center for Chronic Disease Prevention and Health Promotion supporting the Adelphi NY Statewide Breast Cancer Hotline and Support Program, which provides toll-free counseling and social work services to breast cancer patients, with emphasis on young survivors and metastatic patients in underserved populations. NSF STEM Education funding (CFDA 47.076) for undergraduate scholar support and NSF Biological Sciences grants (CFDA 47.074) for prebiotic chemistry research represent the university's largest single research commitments.

In its sub-recipient role, Adelphi appears primarily on neuroscience and health services research sub-awards from Rutgers University, The Research Foundation for the State University of New York, Brown University, and Columbia University, typically contributing subject-matter expertise in neurocognitive aging, marine ecosystem science, and nurse-led end-of-life care interventions. Activity has held steady at 3 to 8 awards per year over the past five years, with 2022–2023 focused on COVID-19 emergency response and 2024–2026 shifting to baseline research and educational programming. Four awards reach ultimate completion within the next twenty-four months, triggering modest recompete exposure. Combined obligated dollars across all 85 awards total approximately $75 million, with combined potential value of $148 thousand — a structural artifact reflecting grant accounting conventions where potential value often excludes obligated amounts that have already been expended.